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SUMMARY
The aim of the study was to evaluate the functional state of peripheral blood neutrophils in patients with chro-
nic active viral hepatitis. Twenty-six patients with HBV, HCV or CMV in different clinical status were included
in the analysis. In the study, the number of leukocytes and neutrophils was determined. The metabolic activity
of neutrophils was examined in NBT reduction tests i.e. spontaneous (NBTsp) test and the one stimulated with
LPS E. coli (NBTst). The results were analysed in relation to disease advancement and the type of viral infec-
tion. The data obtained from the affected patients were compared with the results from 46 healthy subjects.
Most patients displayed neutropenia. It was found that the number of NBT positive cells and the coefficient of
neutrophil metabolic activity (CNMA) in NBT sp test were highly significantly increased. The majority of
patients had reduced values in NBTst test, which suggested lack of response to LPS E. coli by neutrophils.
These findings may reflect the state of inflammation in the body. NBT reduction tests may be useful in monitor-
ing metabolic activity of neutrophils in patients with chronic active viral hepatitis.
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INTRODUCTION
Among viral hepatitis with progressing changes in
hepatocytes, the term ’chronic’ applies to those
cases of hepatitis when virus is not eliminated
within 6 months. Viral hepatitis include HAV, HBV,
HCV, HDV, CMV, EBV and HSV. The pathogenic
factors responsible for hepatocyte damage in
chronic hepatitis are specific and non-specific
mechanisms, mediated by the immune system and
immune reactivity of the affected patient is strictly
related to the development of chronic infection.
The changes observed in the liver after infection
result both from local and general response to
infection and are manifested in clinical symptoms
and laboratory parameters. People with chronic
hepatitis display hypergammaglobulinaemia with
respect to the levels of IgG, IgA and IgM in blood
serum and hepatocytes [1—4].
In liver diseases, neutrophils, lymphocytes and
many other cells cumulating at the site of inflamma-
tion induce vascular and parenchymal damage of
the liver. They are also present in blood stream. The
infected cells are eliminated if they are recognised
by natural killer cells and cytotoxic T cells [1—3,5].
Neutrophils, representing the most numerous
group of leukocytes in peripheral blood, are invol-
ved in a variety of pathophysiological processes in
the body and due to their metabolic, synthetic and
secretory activity they play an important role in
immunoregulation. Their stimulation as a result of
inflammation has a beneficial effect if it intensifies
the inactivation of infection factors, but it may well
have negative consequences, when neutrophils
destroy host’s cells. Qualitative and quantitative
neutrophil dysfunction is observed in various disea-
se entities [6—13].
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The aim of the study was to evaluate the functional
status of neutrophils in peripheral blood of patients
with chronic viral hepatitis. It was important to
establish whether pathological status was reflected
in metabolic activity of peripheral blood neu-
trophils, determined in NBT reduction tests.
MATERIAL AND METHODS
The analysis was based on 26 patients, both males
and females, aged 22—75 years, with the diagnosis
of chronic active viral hepatitis. In the analysis, the
type of virus (HBV, HCV, CMV) and clinical status
(a — light, b — moderate, c — severe) based on
Child-Pough’s score were taken into account. This
punctual score includes such parameters as albu-
min and bilirubin levels, prothrombin index,
hydroperitoneum and hepatic encephalopathy.
HBV was diagnosed in 19 patients, HCV — in 5,
cytomegaly — in 2. Clinical status was light in 5 sub-
jects, moderate in 9 and severe in 12. The patients
underwent diagnostic investigations and treatment
in Chair and Department of Gastroenterology,
Collegium Medicum, Jagiellonian University in
Cracow.
The number of leukocytes, proportional content
and absolute value of neutrophils were calculated.
Metabolic activity of neutrophils was determined
with the use of nitroblue tetrazolium spontaneous
(NBTsp) and stimulated (NBTst) reduction tests, fol-
lowing the methodology described by Park et al.
[14], Park and Good [15], with our own modifica-
tions.
The results in 46 healthy subjects were considered
normal reference values for peripheral blood neu-
trophils [16].
NBT-sp reduction test
0.1 ml of 0.1% NBT solution was added to 0.1 ml
heparinised venous blood (50 u/ml). After 15
minute incubation at 37¡C and 15 minute incuba-
tion at room temperature, the smears were pre-
pared. After May-Grnwald Giemza staining, the
percentage of NBT-positive cells with black for-
mazan inside them was evaluated.
NBT-st reduction test
Lipopolysaccharide (LPS) E. coli — Pyrogen manu-
factured by Biomed, Cracow — was used for the
stimulation of metabolic activity of peripheral
blood neutrophils.
4 mg LPS E. coli in 0.02 ml Krebs-Ringer solution
was added to 0.1 ml heparinised venous blood.
After 10-minute incubation at room temperature,
0.1 ml of 0.1% NBT solution was added, and the
procedure was repeated as in NBT-sp test.
Statistical analysis 
The results are presented as mean absolute values
with standard deviations and with the coefficient of
neutrophil metabolic activity (CNMA), calculated
from the proportion of percentage values of NBT-
positive cells observed in the examined subjects to
NBT-positive values in control group.
T-Student test and Statistica for Windows were
used for the comparison of study results.
RESULTS
Table 1 presents the number of leukocytes and
neutrophils in peripheral blood of patients with
hepatitis, with respect to virus type and clinical sta-
tus and in relation to normal values. Fifty-three per
cent of patients with HBV had leukopenia and
63% displayed neutropenia. This group included
the most patients with severe clinical condition.
The analysis of 26 patients without reference to
virus type revealed that 46% of them had reduced
leukocyte count and 58% — reduced neutrophil
count.
Table 2 demonstrates the results of metabolic
activity of peripheral blood neutrophils in NBT-
sp test with respect to normal values. The former
were shown as absolute values of NBT positive
cells and relative CNMA values, with regard to
virus type and clinical status. Elevated values of
NBTsp test and relative CNMA test were found in
most patients with HBV, among whom subjects
with moderate and severe clinical status pre-
vailed. Higher values of NBTsp and CNMA tests
were also observed in patients with HCV. In
total, the majority of 26 subjects displayed 2 — 6
times higher values of NBT-positive cells and
CNMA.
Table 3 provides data on NBT test stimulated with
LPS E. coli (NBTst LPS). In HBV patients, lower val-
ues of NBT-positive cells were found in 15 subjects
and lower CNMA values — in 10. Reduced values
of the test and CNMA were observed in patients
with CMV. Out of all the subjects with chronic
active viral hepatitis, 73% had lower values of NBT
positive cells and 54% — lower CNMA values.
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DISCUSSION
The analysis of patients with the diagnosis of
chronic, active, viral hepatitis revealed reduced
number of neutrophils in peripheral blood in most
subjects, particularly in patients whose clinical sta-
tus was moderate or severe. Neutrophils as the first
defence line play an important role in the body,
Number of neutrophils
N decreased N normal N increased
3020–2972NS
** p 0.02—0.01, *** p 0.005—0.001, **** p 0.0005—0.0000...1, a, b, c — degree of viral advances
2718–574**
4362–5838NS
2163–1199****
2974–3339NS
2773NS
2552–555**
7008****
3488–2009NS
2291–1342**
3696–781
15 1773–671
2
5
5
12
2
2
1
2305–274
1995–753
1241–526
1732–717
2236–129
2236–129
1342
9 3191–404
2
4
6
1
1
2
1
3130–482
3315–525
3254–470
2773
3185
2979–291
3240
2 11604–6500
1
1
1
1
16200
16200
7008
7008
Patients
Number of leukocytes
N N decreased N normal N increased
26 4965–3078NS
HBV
S
HCV
S 
CMV
Control
a
b
c
a
b
c
c
4
6
9
19
1
3
1
5
2
46
Patients
N
26
HBV
S
HCV
S 
CMV
Control
a
b
c
a
b
c
c
4
6
9
19
1
3
1
5
2
46
4262–736***
6875–5605NS
3633–1085****
4789–3394NS
4700NS
5117–1308NS
9600****
5930–2258NS
4225–1662
5826–987
12 3217–579
1
2
7
10
1
1
1
3200
3050–212
3193–718
3165–594
3900
3900
3050
12 5242–616
3
3
2
8
1
2
3
1
4617–247
5717–29
5175–460
5169–554
4700
5725–1096
5383–975
5400
2 13800–5940
1
1
1
1
18000
18000
9600
9600
Table 1. Peripheral blood neutrophils in patients with chronic, viral hepatitis.
The relationship between clinical status, viral infection and normal values.
Patients
NBT positive cells in NBT sp test
CNMAsp
N
26 1082–1770***
HBV
S
HCV
S
CMV
Control
a
b
c
a
b
c
c
4
6
9
19
1
3
1
5
2
46
644–480***
1996–3637***
637–359****
1068–2047**
1747****
1535–575****
701***
1411–576****
393–177NS
309–129
N increased
18 1439–2039
3
4
5
12
1
3
1
5
1
817–409
2884–4346
869–299
1527–2494
1747
1535–575
701
1411–576
518
N normal
5 370–83
1
3
4
1
328
417–66
395–70
268
N decreased
3 126–11
1
1
1
3
127
114
136
126–11
3.56–1.93****
2.39–1.40****
3.24–1.79****
3.24–1.79****
3.21–1.50****
6.93****
6.49–1.05****
1.10NS
5.50–2.58****
1.98–0.31****
1.0–0.21
Table 2. Metabolic activity of neutrophils in spontaneous NBT test (NBTsp).
Mean absolute number of NBT positive cells, depending on degree of disease advances and types of virus infection and the coefficient of
neutrophil metabolic activity (CNMA) in NBTsp test were expressed.
** p 0.02—0.01, *** p 0.005—0.001, **** p 0.0005—0.0000...1, a, b, c — degree of viral advances
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their deficiency manifested in neutropenia or dys-
function may have serious clinical consequences.
Patients with cirrhosis often display neutropenia
and reduced cell viability, which makes them vul-
nerable to bacterial infections. In these patients,
neutropenia may result partly from markedly ele-
vated apoptosis in vitro [9—11,17,18].
NBT tests which are widely used in laboratory
diagnostics of various diseases, allow for the deter-
mination of phagocytosis and metabolic activity of
neutrophils [10,16,19—22]. In 69% analysed pa-
tients, the values of NBTsp test and CNMAsp were
2—6 times higher. The clinical status of 78% of the-
se subject was moderate or severe. Elevated values
in NBTsp test might suggest an ongoing inflamma-
tory process, induced by viruses, their products or
other micro-organisms. In HCV infected patient,
the sequences of viral genome may be detected in
medullary haematopoietic cells and mononuclear
cells in peripheral blood, i.e. phagocytes (neutro-
phils, monocytes/macrophages) and B cells. In pa-
tients with disseminated human cytomegalovirus,
the infectious virus, viral DNA and HCMVpp65
antigen were found in neutrophils. Possible pene-
tration and replication of viruses in immune system
cells has a detrimental effect on normal cell func-
tion [23,24].
The liver is the main organ involved in endotox-
aemia and responding to LPS. Patients with chron-
ic viral hepatitis often display increased blood le-
vels of endotoxins and systemic endotoxaemia as
well as elevated concentration of soluble receptor
sCD14 for LPS. This contributes to the disorders
accompanying these diseases. It was observed that
intravenous LPS administration to experimental
animals is the cause of pathological changes in the
liver characterised by the infiltration of platelets
and neutrophils, sequestration of inflammatory
cells in vessels, migration through endothelium and
adhesion to hepatocytes as well as the release of
cytotoxic mediators responsible for hepatocyte
necrosis [5,25—29]. Peripheral blood neutrophils
isolated from the majority of patients did not
respond to LPS E. coli stimulation. It was manifest-
ed in reduced NBTst and CNMAst values, particu-
larly in patients with moderate or severe condition.
The impairment of neutrophil response to LPS E.
coli stimulation might result from the activation of
these cells before extravasation. Neutrophils fully
activated in vivo did not respond to the stimulant
(LPS) in vitro. This would suggest lack of ’functional
reserve of the cells’ able to fulfil additional func-
tion, thus making the patient’s body susceptible to
further infections.
The evaluation of the function of peripheral blood
neutrophils seems significant in the assessment of
chronic active viral hepatitis. The sequence of phe-
nomena taking place in the body affected by in-
flammation usually lead to the impairment of im-
mune system reactivity. It was manifested in neu-
tropenia or disturbances in metabolic activity of
neutrophils diagnosed in the analysed group of
patients. The complexity of chronic active hepatitis
is further enhanced by possible development of
autoimmune diseases, when auto-antibodies may
bind with antigens in situ in hepatocytes and cause
further destruction [1,2,4]. It seems important to
start adequate treatment with special reference to
biologically active drugs/preparations, which have
Patients
NBT positive cells in NBT st test CNMAst
N
26 1022–1155NS
HBV
S
HCV
S
CMV
Control
a
b
c
a
b
c
c
4
6
9
19
1
3
1
5
2
46
873–474
803–1745NS
723–398****
1024–1312NS
1081NS
1195–847NS
1472NS
1228–616NS
497–305**
1385–451
N normal
12 1.01–0.15
2
2
5
9
1
2
3
0.93–0.17
1.17–0.35
1.09–0.17
1.07–0.20
0.96
1.30–0.52
1.19–0.42
N decreased
14 0.58–0.10
2
4
4
10
1
1
2
2
0.56–0.24
0.56–0.12
0.62–0.07
0.59–0.12
0.64
0.51
0.57–0.09
0.52–0.02
N increased
1 6156
1
1
6156
6156
N normal
6 1559–350
1
1
1
3
1
1
1
3
1493
1534
1606
1544–57
1081
2166
1472
1573–550
N decreased
19 583–237
3
4
8
15
2
2
2
667–285
440–251
612–237
577–247
710–148
710–148
497–305
0.82–0.32**
0.74–0.27
0.77–0.36
0.88–0.28NS
0.82–0.30**
0.96NS
1.08–0.53NS
0.51
0.94–0.45NS
0.52–0.02**
1.0–0.24
Table 3. Effect of LPS E. coli on metabolic activity of neutrophils in NBT stimulated test (NBTst LPS) expressed in mean absolute number of NBT
positive cells and the coefficient of neutrophil metabolic activity (CNMA).
** p 0.02—0.01, *** p 0.005—0.001, **** p 0.0005—0.0000...1, a, b, c — degree of viral advances
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a stimulating/inhibiting effect on immune system
and a regenerating or adjuvant action, e.g. ubiqui-
tin complex, interferon alpha [2,30—33].
CONCLUSIONS
1. The following were observed in most patients
with chronic active viral hepatitis: a) neutrope-
nia; b) elevated NBTsp and CNMAsp values; c)
reduced NBTst and CNMAst values, which indi-
cates the absence of Ôfunctional reserve of the
cellsÕ, capable of additional response to LPS
stimulation measured in vitro.
2. Our findings confirm the presence of inflamma-
tion and reflect the involvement of peripheral
blood neutrophils in this process.
3. Monitoring functional status of peripheral blood
neutrophils in NBT reduction tests is an easy-to-
use method which may be employed during the
treatment of patients with chronic active viral
hepatitis.
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